AIDS Treatment News
Table of Contents, October 26, 2004

• New Fixed-Dose Once-a-Day Starting Regimens: Interview With Cal Cohen, M.D.
  A leading AIDS physician looks at the advantages and disadvantages of once-a day treatment with two new fixed-dose combinations of previously approved drugs, for patients who are first starting antiretrovirals.

• Depression: Louganis and Allen to Speak at Forums in New York and San Francisco Oct. 27
  Diver Greg Louganis and actor Chad Allen spoke in New York at a public forum to raise awareness of depression in the gay community. They will speak again in San Francisco.

• Warning Against Using Erythromycin (Even Orally) While Using Protease Inhibitors or Certain Other Drugs
  A study of medical records found that combining the antibiotic erythromycin with strong inhibitors of the liver enzyme CYP3A increased the risk of sudden death from cardiac causes -- probably by abnormally raising the blood levels of erythromycin.
  Advertisement

• Kaletra Monotherapy Controversy: amfAR Publishes Overview
  The possibility of using Kaletra alone for selected patients instead of three or more antiretrovirals has led to controversy among HIV physicians, reviewed in a short article published by the American Foundation for AIDS Research.

• Access to NIH-Funded Research Information -- Public Comment Period to November 16, 2004
  The U.S. National Institutes of Health has proposed making reports of NIH-funded research freely available six months after their commercial publication. We show why this proposal is a step forward but far from a solution to the problem. We also refer readers to a micropayment idea we developed that might ease some of the remaining problems.

ISSN # 1052-4207

Copyright 2004 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.